Biocare Meditech Private Limited
Biocare Meditech Private Limited is a Private Non-govt company company incorporated in 2011 and based in Punjab, India. Biocare Meditech Private Limited operates in Medical & Precision (NIC 33110) with authorized capital of ₹80.00 L and paid-up capital of ₹72.66 L. For 2023-24, the company reported revenue of ₹15.96 Cr and profit after tax of ₹70.98 L. The board has 1 active director. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
Quick facts
Directors
1 activeMCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 23 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | +32d | filed |
| MGT-7 | FY2023-24 | 23 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | +38d | filed |
| MGT-7 | FY2022-23 | 27 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Biocare Meditech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 157701561 | ICICI Bank Ltd(Bank) | ₹9.86 Cr | 04 Jul 2022 | Satisfied |
| 435279098 | ICICI Bank Ltd(Bank) | ₹14.16 Cr | 27 Jan 2023 | Open |
| 290093512 | ICICI Bank Ltd(Bank) | ₹10.92 Cr | 27 Jan 2022 | Open |
| 260787272 | ICICI Bank Ltd(Bank) | ₹20.20 Cr | 04 Jul 2022 | Open |
| 646694833 | Axis Bank Ltd(Bank) | ₹10.36 Cr | 12 Mar 2020 | Open |
Charge IDs, lenders & amounts for Biocare Meditech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2023-24 | — | ||||
| 2022-23 | — | ||||
| 2021-22 | — | ||||
| 2020-21 | — | ||||
| 2019-20 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — | ||||
| 2015-16 | — |
Detailed Financials
4 FYs| Line item | 2023-24 | 2022-23 | 2021-22 | 2020-21 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2023-24 | +71.0% | +88.0% | +52.0% | |
| Profit after Tax2023-24 | +53.0% | +78.0% | +2.0% | |
| Net Worth2023-24 | +58.0% | +41.0% | +56.0% |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | +1.34% | — | +9.50% | +2.27% | 4.18 | |||
| 2016-17 | +1.42% | +78.96% | +15.23% | +2.81% | 5.41 | |||
| 2017-18 | +2.87% | -5.26% | +22.57% | +5.12% | 4.41 | |||
| 2018-19 | +5.54% | -22.75% | +25.21% | +9.60% | 2.63 | |||
| 2019-20 | +5.33% | +3.74% | +20.09% | +6.27% | 3.20 | |||
| 2020-21 | +5.95% | -16.87% | +15.71% | +6.76% | 2.32 | |||
| 2021-22 | +6.13% | +42.15% | +18.71% | +7.44% | 2.51 | |||
| 2022-23 | +4.49% | +15.44% | +13.66% | +5.30% | 2.58 | |||
| 2023-24 | +4.45% | +16.19% | +13.59% | +5.02% | 2.70 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,25,19,747 | 68.23% |
| Institutional Investors | 1 | 20,60,039 | 11.23% |
| Public & Others | 37 | 37,69,304 | 20.54% |
Promoter, institutional & public holding for Biocare Meditech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
500 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.